Moderna And Novavax Stocks Fall On IP Waiver Concerns, But Sell Off Is Overdone
- Tuesday, May 11, 2021, 7:15
- Market
- Add a comment
Vaccine stocks had a rough week, with Novavax stock down almost -25%, Moderna down by about -9%, and Pfizer stock up by just about 2% despite posting a very solid set of first-quarter results. The decline is largely driven by the Biden administration’s support of the temporary waiver of…
About the Author
admin123 has written 23527 stories on this site.
